Arctic
Invent
Case Registry
Dashboard
Case Explorer
Back to Explorer
Update Case Entry
Manually curate individual case documents inside the PostgreSQL engine.
Case Lawsuit Title
*
Case / Trial ID Number
Jurisdiction Code
*
us
in
upc
eu
Category
*
Patent
Trademark
Copyright
Design
Filing Date
Decision Verdict Date
Court / Tribunal
Bench / Panel Judges
Petitioner / Claimant (Plaintiff)
Bayer Corporation
Respondent / Defendant
Union of India
Dispute Summary
Bayer Corporation, holding a patent for the drug Sorafenib tosylate, challenged the licensing process of its competitor, Cipla, arguing that Cipla's application for 'Soranib' constituted an infringement. Bayer contended that granting the license would violate Section 48 of the Patents Act and contravene the definition of a 'spurious drug' under the Drugs and Cosmetics Act. The Delhi High Court ultimately dismissed the writ petition, holding that unpatented drugs cannot be deemed 'spurious drugs,' thereby upholding the procedural integrity of the licensing process.
Outcome / Ruling
defendant_favorable
Verdict Document PDF URL
Full text judgment
Cancel
Update Case